Accelerate to discover

Back to filter

Related topics

Quantitative characterization of metaphase cellular events using 3D imaging cellular events 

Yokogawa

Sep 20, 2018

In conventional monolayer cell culture systems, cell nuclei show dynamic and cyclic changes in theirshape and height....

A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy

Spectral Instruments Imaging

Sep 18, 2018

A polymeric conjugate, composed of a carboxymethyl dextran (CMD) as the backbone and ovalbumin (OVA) as a model foreign...

Adenovirus type B detection using the xxpress qPCR thermal cycler

BJS Biotechnologies

Sep 17, 2018

The ultrafast xxpress qPCR thermal cycler through performing standard dilution series and multiplex qPCR experiments is...

BluePippin-DNA size selection for NGS with pulsed-field (100bp-50kb)

Sage Science

Sep 3, 2018

Highly sensitive detection of mutations in CHO cell recombinant DNA uses multi‐parallel single molecule real‐time DNA...

Sep 23, 2018

IncuCyte webinar: Live-cell analysis of cell subsets and heterogeneity

Sartorius

Sep 3, 2018

Discover the new IncuCyte S3 cell-by-cell analysis software module. The innovative module allow label free analysis to...

Diagnosis of Acute Cellular Rejection Using Probe-Based Confocal Laser Endomicroscopy in Lung

Mauna Kea Technologies

Sep 3, 2018

Mauna Kea Technologies announced the publication of a prospective multicenter study that demonstrates the potential of...

ACEA Biosciences introduces an exploratory xCELLigence RTCA S16 instrument

Acea Biosciences

Aug 30, 2018

The company has just introduced the xCELLigence RTCA S16, which is the ideal entry level model for exploratory studies...

Sep 23, 2018

Register for Bionano genomics October 2018 user group workshop

BioNano Genomics

Aug 27, 2018

Registration for Bionano’s fall user group workshop is now open. The fall session is being held at Bionano's San Diego...

Show all topics (10)

Investigating the hallmarks of cancer using xCELLigence system

Feb 24, 2017

Early hopes of finding a therapeutic “magic bullet” capable of eradicating all types of cancer were progressively replaced with the sobering realization that cancer consists of >100 distinct diseases that manifest in ~200 cell types with diverse genetic/mutational etiologies. For the clinician this complexity is compounded by the fact that a single disease phenotype can result from multiple genotypes, each of which requires a unique approach to treatment (estrogen dependent/independent breast cancer being a primary example). Citing that the cancer scientific literature had already become “complex almost beyond measure,” in  2000 Robert Weinberg and Douglas Hanahan stated a belief that “the complexities of the disease, described in the laboratory and the clinic, will become understandable in terms of a small number of underlying principles.”In this now famous paper they suggested that distillation of decades of research reveals “a small number of molecular,biochemical, and cellular traits – acquired capabilities – shared by most and perhaps all types of human cancer.”

Read more

Scientific paper
Technical breakthrough
Product news

Related technologies: Real-time, label free cell analysis

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

Acea Biosciences

ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.

Related products

The RTCA DP Analyzer has three integrated stations for E-Plates 16 or CIM-Plates 16

show detail

Located inside a tissue culture incubator, it is capable of switching any one of the wells on the E-Plate 96 to the RTCA Analyzer for impedance measurement

show detail

Located inside a tissue culture incubator, it is capable of switching any one of the wells on any of six E-Plates to the RTCA Analyzer for impedance measurement

show detail

Instrument can be integrated with automated liquid handling platforms or a robotic plate handler from different vendors

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey